The impact of coronavirus-19 vaccination on anti-nuclear cytoplasmic antibody vasculitis hospitalisations in a Sydney health network.
Intern Med J
; 54(3): 483-487, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-38404157
ABSTRACT
There have been reports of COVID-19 vaccination triggering anti-nuclear cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but no robust studies have examined the link. This retrospective cohort study assessed the impact of COVID vaccination on the rate of denovo and relapsed AAV in a Sydney Local Health District from 2018 to 2022. Despite more than 95% of the population receiving vaccination, the case rate of AAV was stable. These findings do not support a relationship between COVID vaccination and AAV.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Granulomatose com Poliangiite
/
Coronavirus
/
Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos
/
Poliangiite Microscópica
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article